首页> Journal of Pharmaceutical and Biomedical Analysis: An International Journal on All Drug-Related Topics in Pharmaceutical, Biomedical and Clinical Analysis> Development and validation of a liquid chromatographic-tandem mass spectrometric assay for the quantification of the direct acting antivirals glecaprevir and pibrentasvir in plasma

Development and validation of a liquid chromatographic-tandem mass spectrometric assay for the quantification of the direct acting antivirals glecaprevir and pibrentasvir in plasma

导出原文传递

翻译打印收藏纠错

第一作者： Garza K.Y.

作者： Garza K.Y. ^[1] ; Pandey A. ^[2] ; Marzinke M.A.

作者单位： Department of Pathology Johns Hopkins University School of Medicine ^[1] Department of Medicine Johns Hopkins University School of Medicine ^[2]

关键词 Direct acting antivirals Glecaprevir Hepatitis C LC-MS/MS Mass spectrometry Pibrentasvir

发布时间 2024-05-13

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Journal of Pharmaceutical and Biomedical Analysis

2023年235卷

115629-115629页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

Journal of Pharmaceutical and Biomedical Analysis

2023年235卷

115629-115629页

检索历史清除

Development and validation of a liquid chromatographic-tandem mass spectrometric assay for the quantification of the direct acting antivirals glecaprevir and pibrentasvir in plasma

Journal of Pharmaceutical and Biomedical Analysis

相似文献

同项目论文

Journal of Pharmaceutical and Biomedical Analysis

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Development and validation of a liquid chromatographic-tandem mass spectrometric assay for the quantification of the direct acting antivirals glecaprevir and pibrentasvir in plasma

Journal of Pharmaceutical and Biomedical Analysis

相似文献

同项目论文

Journal of Pharmaceutical and Biomedical Analysis

相关期刊

检索历史清除